Native-native 2D gel electrophoresis for HDL subpopulation analysis

Methods in Molecular Biology

Volumn 1027, Issue , 2013, Pages 353-367

  Freeman, Lita A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

2D gel electrophoresis; Apolipoprotein A I; HDL particles; HDL subpopulations; Lipoproteins; Particles; Particles

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; IODINE 125; ANTIBODY; RADIOACTIVE IODINE;

ARTICLE; CHEMOLUMINESCENCE; PRIORITY JOURNAL; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; CHEMISTRY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES;

ANTIBODIES; APOLIPOPROTEIN A-I; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IODINE RADIOISOTOPES; LIPOPROTEINS, HDL;

EID: 84922815648     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-369-5_17     Document Type: Article

References (17)

1. Gotto A, Pownall H (2003) Manual of lipid disorders: Reducing the risk for coronary heart disease. Lippincott, Williams and Wilkins, Philadelphia, PA.
2. Asztalos BF, Sloop CH, Wong L, Roheim PS (1993) 2-dimensional electrophoresis of plasma-lipoproteins -recognition of new apo-A-I-containing subpopulations. Biochim Biophys Acta 1169:291-300
3. Asztalos BF, Brousseau ME, McNamara JR, Horvath KV, Roheim PS, Schaefer EJ (2001) Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease. Atherosclerosis 156:217-225
4. Asztalos BF, Horvath KV, Kajinami K, Nartsupha C, Cox CE, Batista M, Schaefer EJ, Inazu A, Mabuchi H (2004) Apolipoprotein composition of HDL in cholesteryl ester transfer protein de ficiency. J Lipid Res 45:448-455
5. Asztalos BF, Schaefer EJ, Horvath KV, Yamashita S, Miller M, Franceschini G, Calabresi L (2007) Role of LCAT in HDL remodeling: Investigation of LCAT de fi ciency states. J Lipid Res 48:592-599
6. Santos RD, Schaefer EJ, Asztalos BF, Polisecki E, Wang J, Hegele RA, Martinez LRC, Miname MH, Rochitte CE, Da Luz PL, Maranhao RC (2008) Characterization of high density lipoprotein particles in familial apolipoprotein A-I de ficiency. J Lipid Res 49:349-357
7. Wada M, Iso T, Asztalos BF, Takama N, Nakajima T, Seta Y, Kaneko K, Taniguchi Y, Kobayashi H, Nakajima K, Schaefer EJ, Kurabayashi M (2009) Marked high density lipoprotein de fi ciency due to apolipoprotein A-I Tomioka (codon 138 deletion). Atherosclerosis 207(1):157-161
8. Schaefer EJ, Asztalos BF (2007) Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Am J Cardiol 100:n25-n31
9. Asztalos BF, Roheim PS, Milani RL, Lefevre M, McNamara JR, Horvath KV, Schaefer EJ (2000) Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20:2670-2676
10. Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ (2002) Comparing the effects of fi ve different statins on the HDL subpopulation pro files of coronary heart disease patients. Atherosclerosis 164:361-369
11. Asztalos BF, Batista M, Horvath KV, Cox CE, Dallal GE, Morse JS, Brown GB, Schaefer EJ (2003) Change in alpha(1) HDL concentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol 23:847-852
12. Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ (2004) High-density lipoprotein subpopulation pro fi le and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24:2181-2187
13. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloom fi eld HE, Robins SJ, Schaefer EJ (2005) Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 25:2185-2191
14. Davidson WS, Silva RA, Chantepie S, Lagor WR, Chapman MJ, Kontush A (2009) Proteomic analysis of de fi ned HDL subpopulations reveals particle-specific protein clusters: Relevance to antioxidative function. Arterioscler Thromb Vasc Biol 29:870-876
15. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiin fl ammatory properties of HDL. J Clin Invest 117:746-756
16. Gonzalez-Navarro H, Nong Z, Amar MJ, Shamburek RD, Najib-Fruchart J, Paigen BJ, Brewer HB Jr, Santamarina-Fojo S (2004) The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice. J Biol Chem 279:45312-45321
17. Warnick GR, McNamara JR, Boggess CN, Clendenen F, Williams PT, Landolt CC (2006) Polyacrylamide gradient gel electrophoresis of lipoprotein subclasses. Clin Lab Med 26:803-846